Two members of Internal Medicine recently had their proposals approved by University of Iowa and Mayo Clinic (UI/MC) Lymphoma SPORE leadership. Namrata Singh, MD, MSCI, FACP, Clinical Assistant Professor in Immunology, has received a one-year, $50,000 Career Enhancement Program (CEP) Award for her proposal “Prevalence and the impact of hypogammaglobulinemia in newly diagnosed, untreated lymphoma patient.” Fenghuang Zhan, MD, PhD, Professor in Cardiovascular Medicine, has had the second year of his Developmental Research Program (DRP) application, “The USP7 Inhibitor prevents NEK2-driving lymphoma,” funded at the same level. Both Dr. Singh’s and Dr. Zhan’s proposals are seed grants, which could potentially lead to larger projects depending on their discoveries.
For more than 15 years, investigators at the UI/MC SPORE (Specialized Program of Research Excellence) have advanced our understanding of lymphoma. The funds the National Cancer Institute provides in this collaborative program fuels a variety of activities from basic and population-based research to clinical trials. On a regular basis, leadership within the SPORE identify promising research proposals for funding. Jon Houtman, PhD, leads the CEP at Iowa, and Steven Lentz, MD, PhD, leads the DRP. Learn more about the UI/MC Lymphoma SPORE: https://uihc.org/lymphoma-spore